glucose analogues that selectively inhibit cellular α-glucosidase I and II in the endoplasmic
reticulum and exhibit antiviral activities against many types of enveloped viruses. Although
these molecules have broad-spectrum antiviral activity, their development has been limited
by a lack of efficacy and/or selectivity. We have previously reported that a DNJ derivative
with a hydroxylated cyclohexyl side chain, called OSL-95II, has an antiviral efficacy similar to …